文献速递胸部技术与安全CT

基于人群调查的肺癌筛查利用预测因素

Predictors of Lung Cancer Screening Utilization in a Population-Based Survey.
PubMed 文献 · J Am Coll Radiol · 2020-07-16

研究分析2017年行为危险因素监测系统中实施肺癌筛查模块的10个州数据,采用加权Logistic混合效应模型,发现无保险者接受低剂量CT筛查的可能性较低(OR 0.28),而患有慢性呼吸系统疾病、既往癌症诊断及65-74岁人群筛查利用率较高,且各州间利用率存在显著差异。

要点

  • 无保险人群低剂量CT筛查利用率显著低于有保险者(OR 0.28,95%CI 0.12-0.65)。
  • 慢性呼吸系统疾病患者筛查利用率较高(OR 4.14,95%CI 2.33-7.35)。
  • 既往癌症诊断者及65-74岁人群低剂量CT筛查利用率较高。

核心结论

  • 与早期筛查获益相关的健康状况(如其他癌症诊断、慢性呼吸系统疾病)及拥有保险覆盖与更高的低剂量CT筛查利用率相关。
  • 提供者应通过知情和共享决策与符合低剂量CT筛查条件的患者互动,以增加偏好敏感的筛查决策。

研究设计与样本

  • 研究类型为基于人群的调查分析,数据来源于2017年行为危险因素监测系统的肺癌筛查模块及核心模块,通过手机和固定电话实施。
  • 分析纳入实施筛查模块的10个州的数据,采用加权频率和置信区间,加权Wald χ2检验比较不同患者特征的筛查利用率差异。
  • 构建多变量Logistic混合效应模型,以随机截距校正参与者按州的聚类效应。

诊断标准与关键数值

  • 无保险者接受低剂量CT筛查的比值比(OR)为0.28(95%CI 0.12-0.65)。
  • 慢性呼吸系统疾病患者接受低剂量CT筛查的OR为4.14(95%CI 2.33-7.35)。
  • 离婚、分居、丧偶或拒绝回答婚姻状况者接受低剂量CT筛查的OR为1.41(95%CI 1.05-1.86)。
  • 既往癌症诊断者接受低剂量CT筛查的OR为1.90(95%CI 1.40-2.56)。
  • 65至69岁人群接受低剂量CT筛查的OR为1.23(95%CI 1.06-1.44),70至74岁人群OR为1.17(95%CI 1.00-1.37)。

临床应用与阅片要点

  • 原文结论指出提供者应通过知情和共享决策与符合低剂量CT筛查条件的患者互动,以增加偏好敏感的筛查决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Annual low-dose CT (LDCT) screening in high-risk individuals has been recommended to detect lung cancer earlier and reduce mortality. The objective of this study was to identify demographic, financial, and health care factors associated with screening uptake in a population-based survey.

METHODS: Data from the Lung Cancer Screening Module and core modules of the 2017 Behavioral Risk Factor Surveillance System, a population-based survey administered via cell phone and landline, were analyzed to examine demographic, health, and financial factors associated with screening uptake among the 10 states that administered the screening module. Weighted frequencies and confidence intervals (CIs) were produced, and weighted Wald χ2 tests were used to compare differences in screening utilization by patient characteristics. A multivariate logistic mixed-effects model was constructed, in which participant clustering by state was accounted for with a random intercept.

RESULTS: The uninsured were less likely to undergo LDCT screening (odds ratio [OR], 0.28; 95% CI, 0.12-0.65). LDCT screening uptake was higher for participants with chronic respiratory conditions (OR, 4.14; 95% CI, 2.33-7.35); those who were divorced, separated, widowed, or refused to answer (OR, 1.41; 95% CI, 1.05-1.86); those who had previous cancer diagnoses (OR, 1.90; 95% CI, 1.40-2.56); and those aged 65 to 69 years (OR, 1.23; 95% CI, 1.06-1.44) or 70 to 74 years (OR, 1.17; 95% CI, 1.00-1.37). Utilization also varied significantly across states.

CONCLUSIONS: Having a related health condition whereby participants were sensitized to the benefits of early screening (ie, another cancer diagnosis, presence of chronic respiratory conditions) and having insurance coverage were associated with higher LDCT screening uptake. Providers should engage LDCT-eligible patients through informed and shared decision making to increase preference-sensitive screening decisions.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Zgodic A, Zahnd WE, Miller DP, et al. Predictors of Lung Cancer Screening Utilization in a Population-Based Survey. J Am Coll Radiol. 2020. PMID: 32681828. doi:10.1016/j.jacr.2020.06.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。